Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy

NCT03154645 is registered in ClinicalTrials.gov with Grant S Lipman as lead sponsor.

NCT NCT03154645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy
Lead sponsor
Grant S Lipman
Phase
Phase 1
Overall status
Completed
Start date
August 12, 2017
Completion date
October 1, 2017
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute mountain sickness